Literature DB >> 25893409

Positive Margins After Oncoplastic Surgery for Breast Cancer.

Krishna B Clough1, Pedro F Gouveia2, Djazia Benyahi2, Eleanore J D Massey2, Elisabeth Russ2, Isabelle Sarfati2, Claude Nos2.   

Abstract

BACKGROUND: Oncoplastic techniques applied to breast-conserving surgery (BCS) allow large-volume resections without compromising cosmetic results. Level II oncoplastic techniques are based on mammoplasties. When required, they allow resection of more than 20 % of the breast volume; however, a subgroup of these patients will still have positive margins. The clinical management of positive margins after level II oncoplastic surgery (OPS) is a challenge.
METHODS: All patients who had undergone level II oncoplastic techniques at The Paris Breast Center between 2004 and 2013 were reviewed. The choice of the optimal mammoplasty technique was based on the tumor location and the 'quadrant per quadrant atlas'.
RESULTS: A total of 277 level II oncoplastic techniques were performed on 272 patients. The mean tumor size was 26 mm (range 2-160 mm), with a mean resected weight of 175 g (range 50-1540 g). The rate of positive margins was 11.9 %. Risk factors for positive margins identified in univariate analysis were histologic subgroup, tumor size, T stage and grade. In multivariate analysis, only patients with invasive lobular carcinoma had a significantly higher risk of positive margins. A second operation was required in 33 cases, and a third operation was required in three cases because of positive margins. Final breast conservation rate was 91 %.
CONCLUSIONS: Level II OPS results in a low positive margin rate despite large tumor size. Patients with involved margins can be offered a second BCS if the remaining volume allows this.

Entities:  

Mesh:

Year:  2015        PMID: 25893409     DOI: 10.1245/s10434-015-4514-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

1.  Consensus statement on tumour bed localization for radiation after oncoplastic breast surgery.

Authors:  T Tse; S Knowles; J Bélec; J M Caudrelier; M Lock; M Brackstone; A Arnaout
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

Review 2.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

3.  Prognostic factors for residual occult disease in shave margins during partial mastectomy.

Authors:  Julie B Siegel; Rupak Mukherjee; Yeonhee Park; Abbie R Cluver; Catherine Chung; David J Cole; Mark A Lockett; Nancy Klauber-DeMore; Andrea M Abbott
Journal:  Breast Cancer Res Treat       Date:  2021-06-16       Impact factor: 4.872

4.  ASO Author Reflections: Re-Excision for Ductal Carcinoma In Situ: Who Is at Risk?

Authors:  Leslie R Lamb; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-09-18       Impact factor: 5.344

Review 5.  Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?

Authors:  Gilles Houvenaeghel; Agnès Tallet; Aurélie Jalaguier-Coudray; Monique Cohen; Marie Bannier; Camille Jauffret-Fara; Eric Lambaudie
Journal:  World J Clin Oncol       Date:  2016-04-10

Review 6.  Current status of ultrasound-guided surgery in the treatment of breast cancer.

Authors:  José H Volders; Max H Haloua; Nicole Ma Krekel; Sybren Meijer; Petrousjka M van den Tol
Journal:  World J Clin Oncol       Date:  2016-02-10

Review 7.  Oncoplastic partial breast reconstruction: concepts and techniques.

Authors:  Carrie K Chu; Summer E Hanson; Rosa F Hwang; Liza C Wu
Journal:  Gland Surg       Date:  2021-01

8.  Minimalist breast conserving surgical approaches for inferiorly sited cancers.

Authors:  Mona P Tan
Journal:  Gland Surg       Date:  2017-08

9.  Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.

Authors:  Leslie R Lamb; Sarah Mercaldo; Tawakalitu O Oseni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-09-10       Impact factor: 5.344

Review 10.  Evaluating the current evidence to support therapeutic mammoplasty or breast-conserving surgery as an alternative to mastectomy in the treatment of multifocal and multicentric breast cancers.

Authors:  Zoe Ellen Winters; Lorenzo Bernaudo
Journal:  Gland Surg       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.